Epaplus Arthicare Maintenance Instant arôme vanille
Food supplement declared in France, declaration No 2023-4-562, decision dated 13 April 2023
Epaplus Arthicare Maintenance Instant arôme vanille (Epaplus) is a food supplement declared in France. Status: déclaré en France, commercialisation possible : l'administration ne s'est pas opposée à la déclaration (ce n'est ni une autorisation ni une évaluation de sécurité). None of the rules we check flags an issue with its declared composition; vitamin and mineral doses are not published by Compl'Alim and are therefore not checked.
- Brand
- Epaplus
- Food business operator placing the product on the market
- Peroxfarma, S.A.
- Status
- Déclaré en France, commercialisation possible : l'administration ne s'est pas opposée à la déclaration (ce n'est ni une autorisation ni une évaluation de sécurité)
- Form
- Poudre
- Daily dose
- 10,89 g
- Directions for use
- Prendre une mesure de Epaplus Arthicare dissous dans de l'eau, du jus ou un autre liquide (250 ml).
- Not recommended for (according to the manufacturer)
- Enfants (moins de 12 ans), Maladie rénale
- Objectives stated by the manufacturer (these are not authorised claims)
- Articulations
- Flavourings
- Vanille
Declaration 242690, procedure Article 15. Compl'Alim, food supplement declarations (France), retrieved 23 October 2026.
Regulatory points
None of the rules we check applies to the declared ingredients.
Declared composition
Plants
| Plant | Part | Preparation | Per day |
|---|---|---|---|
| Bambusa bambos (L.) Voss | Tige | Autre extrait sec | 57.2 mg |
Other active ingredients
| Name | Per day |
|---|---|
| Collagène hydrolysé | not declared |
| Hyaluronate de sodium | not declared |
Vitamins and minerals
Compl'Alim does not publish vitamin and mineral doses. The references below help you read the product label: EFSAEuropean Food Safety Authority. safety limit for adults and maximum dose set in France per product (Order of 9 May 2006, not revised since November 2006).
| Declared form | Nutrient | EFSA limit, adults | Maximum dose in France |
|---|---|---|---|
| Carbonate de magnésium | Magnésium | 250 mg | 300 mg |
| Chlorhydrate de thiamine | Vitamine B1 (thiamine) | pas de limite (données insuffisantes) | dose annulée par le Conseil d'État en 2011 |
| Riboflavine | Vitamine B2 (riboflavine) | pas de limite (données insuffisantes) | dose annulée par le Conseil d'État en 2011 |
| Chlorhydrate de pyridoxine | Vitamine B6 | 12 mg | 2 mg |
| L-ascorbate de calcium | Vitamine C | pas de limite (données insuffisantes) | 180 mg |
Additives
E330, E955
List from the declaration, administrative decision dated (Compl'Alim, food supplement declarations (France)).
Label warnings
Les compléments alimentaires ne doivent pas être utilisés comme substitut d'un régime alimentaire équilibré. Ne pas dépasser la dose journalière expressément recommandée. Tenir hors de portée des jeunes enfants. Conserver hermétiquement fermé dans un endroit frais et sec. Il est recommandé aux personnes devant suivre un régime pauvre en protéines ou souffrant d'insuffisance rénale de consulter un médecin.
This information reproduces the manufacturer's declaration to the administration (DGAL). It does not say whether the product is effective and does not replace advice from a doctor or pharmacist, particularly during pregnancy or when taking medication.
Official warnings (Health Canada)
Health Canada publishes warnings on these ingredients:
- Collagène hydrolysé
Read the warning, when it applies and the studies cited
Hydrolyzed Collagen
Route of administration: Oral
Cautions and warnings
Condition of application: Joint pain.
Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms worsen.
Applies to products providing more than 2.8 g hydrolyzed collagen, per day.
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are pregnant or breastfeeding (Shils et al. 2006; Goldman and Ausiello 2004).
2 studies cited in the text have no matching reference in the monograph (see the anomalies listed on the sources page).
Known adverse reactions
When using this product you may experience gastrointestinal discomfort/disturbances (Moskowitz 2000).
1 study cited in the text has no matching reference in the monograph (see the anomalies listed on the sources page).
They concern the ingredient, not this product or its dose. They do not replace medical advice.
Brand : Epaplus
Is something on this product wrong or out of date, whether you are a reader or the brand? Write to contact@compoatlas.com: every correction is published in the corrections log.